Delivery Order SPE2DB22D2206-SPE2DB24FEW02
- Not listed
- This federal contract award, valued at $1,801.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,698 units of the prescription medication ramelteon 8 mg tablet, with an ultimate completion date of April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $3,655.53 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 boxes of 8 mg ramelteon tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 2, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information....
- The Defense Logistics Agency awarded a delivery order valued at $1,374.24 to AmerisourceBergen Drug Corp for the supply of Ramelteon 8mg tablets (30-count) on January 15, 2026, with an ultimate completion date of January 16, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Ramelteon is a prescription medication used primarily for the treatment of insomnia. The delivery order...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $89,490 to Amerisourcebergen Drug Corporation to supply 4561368131 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 30 units of the specified pharmaceutical to a facility in Conshohocken, Pennsylvania, under a contract running from June 28 through June 29, 2023. The order is funded through the Defense Logistics Agency's pharmaceutical procurement programs and is not designated for...
- This federal contract award, SPE2DB22D3401|SPE2DB24FT4XB, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $1,148.04 delivery order is for the supply of RAMELTEON 8 MG TABLET 30S medication. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- The Defense Logistics Agency issued a $2,685.99 delivery order to Amerisourcebergen Drug Corp on February 13, 2026, for Ramelteon 8 mg tablets (100 count). The order is placed under the DLA Troop Support Medical indefinite delivery contract, a $999,999,999.00 vehicle through December 2026 supporting global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of February 17, 2026.
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 6.25 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $1,713.22 and has an Ultimate Completion Date of September 10, 2024. AmerisourceBergen, through its Corporate Office division, will be responsible for providing these prescription medications to support military treatment facilities and other federal...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $8,314.30. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,708.13 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The award, valued at $226,242.37, has a firm fixed price and an ultimate completion date of February 20, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEW02Delivery Order
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Ramelteon 8 mg tablets. The Delivery Order contract, valued at $6,303.62, has a completion date of December 29, 2023 and uses a Firm Fixed Price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 12/28/23 |